Logo

Quest

Quest Diagnostics to Offer Agilent Companion Test for Mirati Therapeutics NSCLC Treatment

Agilent's companion diagnostic for Mirati's non-small cell lung cancer treatment Krazati will be available through Quest's national healthcare network.

In Brief This Week: 908 Devices, Natera, PerkinElmer, Hologic, Hamilton, BioFluidiX, More

News items for the week of Nov. 14, 2022

At AMIA, Clinical Decision Support Called Key to Wider PGx Use, Greater Efficacy
Premium

At the AMIA annual symposium, stakeholders discussed barriers to pharmacogenomics adoption and pitfalls in delivering the right information to the right place at the right time.

In Brief This Week: Pacific Biosciences, Pierian, PerkinElmer, Ginkgo Bioworks, More

News items for the week of Oct. 17, 2022.

Meet Ravgen, the Little-Known Company Rattling NIPTs Biggest Players in Court
Premium

The firm alleges its competitors infringe its patents describing processes for finding chromosomal abnormalities in fetal cell-free DNA.

Oct 14, 2022

People in the News at Caris Life Sciences, Quest Diagnostics, LetsGetChecked

Oct 11, 2022

Quest Diagnostics, Ravgen Settle Patent Infringement Suit

Jun 10, 2022

People in the News at Quest Diagnostics, Molecular Assemblies, Informed DNA, More

Mar 23, 2022

Quest Diagnostics Gets FDA Emergency Use Authorizations for DTC COVID-19 Tests, Self-Collection Kit

Oct 20, 2021

Quest Diagnostics, Ginkgo Bioworks Collaborate to Provide COVID-19 Testing for Texas K-12 Schools

Oct 13, 2021

FDA Grants EUAs for Cleveland Clinic COVID-19 PCR Test, Quest Diagnostics Sample Self-Collection Kit

Sep 9, 2021

Blueprint Genetics to Analyze Biobank Samples for Rare Diseases in New Finnish Study

Jul 20, 2021

CLX Health, Quest Diagnostics Partnering to Provide COVID-19 Testing for Events, Travel

Jun 22, 2021

Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test

Jun 16, 2021

Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing

May 10, 2021

CIC Health, Quest Diagnostics Collaborate on COVID-19 School Testing

Feb 23, 2021

Grail Signs on Quest Diagnostics to Provide Phlebotomy for Cancer Detection Test

Jan 21, 2021

Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics
Premium

Jan 19, 2021

Quest Diagnostics Wins CDC Contract to Sequence SARS-CoV-2 Samples

Jan 15, 2021

Ancestry to Discontinue NGS-Based AncestryHealth Service

Dec 21, 2020

Adaptive Biotechnologies, Q2 Solutions Sign Marketing Agreement for ImmunoSeq Assay

Dec 20, 2020

How Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
Premium

Dec 5, 2020

FDA Authorizes Quest Diagnostics SARS-CoV-2/Flu Test With Self-Collection Kit for Emergency Use

Dec 1, 2020

Cepheid, Roche Coronavirus Tests Get FDA Emergency Use Authorization

Nov 12, 2020

Quest Diagnostics Win in Wrongful Death Case Reveals Ongoing Challenges for Variant Classification

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.